HZNP — Horizon Therapeutics Cashflow Statement
0.000.00%
HealthcareBalancedLarge CapHigh Flyer
- $22.82bn
- $23.07bn
- $3.63bn
- 85
- 27
- 73
- 67
Annual cashflow statement for Horizon Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -74.2 | 573 | 390 | 534 | 521 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 202 | 184 | 266 | 310 | 308 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -144 | -2.5 | -346 | -61.7 | -12 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 195 | 426 | 556 | 1,035 | 1,258 |
Capital Expenditures | -4.77 | -17.9 | -170 | -76.6 | -64 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 32.4 | 0 | -294 | -2,918 | -70 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 27.7 | -17.9 | -464 | -2,994 | -134 |
Financing Cash Flow Items | -5.84 | -17 | -66.5 | -166 | -137 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -16.6 | -290 | 905 | 1,470 | -348 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 204 | 118 | 1,003 | -499 | 773 |